CytoMed Therapeutics マネジメント
マネジメント 基準チェック /24
CytoMed Therapeutics' CEO is Wee Kiat Tan, appointed in Feb 2019, has a tenure of 5.75 years. total yearly compensation is SGD116.30K, comprised of 98.3% salary and 1.7% bonuses, including company stock and options. directly owns 0.043% of the company’s shares, worth $11.53K. The average tenure of the management team and the board of directors is 5.5 years and 1.6 years respectively.
主要情報
Wee Kiat Tan
最高経営責任者
S$116.3k
報酬総額
| CEO給与比率 | 98.3% |
| CEO在任期間 | 5.8yrs |
| CEOの所有権 | 0.04% |
| 経営陣の平均在職期間 | 5.5yrs |
| 取締役会の平均在任期間 | 1.6yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -S$3m |
| Mar 31 2024 | n/a | n/a | -S$4m |
| Dec 31 2023 | S$116k | S$114k | -S$4m |
| Sep 30 2023 | n/a | n/a | -S$4m |
| Jun 30 2023 | n/a | n/a | -S$4m |
| Mar 31 2023 | n/a | n/a | -S$4m |
| Dec 31 2022 | S$90k | S$87k | -S$3m |
| Sep 30 2022 | n/a | n/a | -S$3m |
| Jun 30 2022 | n/a | n/a | -S$2m |
| Mar 31 2022 | n/a | n/a | -S$2m |
| Dec 31 2021 | S$83k | S$83k | -S$2m |
| Sep 30 2021 | n/a | n/a | -S$2m |
| Jun 30 2021 | n/a | n/a | -S$2m |
| Mar 31 2021 | n/a | n/a | -S$2m |
| Dec 31 2020 | S$80k | S$80k | -S$2m |
報酬と市場: Wee Kiat's total compensation ($USD87.71K) is below average for companies of similar size in the US market ($USD655.65K).
報酬と収益: Wee Kiat's compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
Wee Kiat Tan (37 yo)
5.8yrs
在職期間
S$116,302
報酬
Dr. Wee Kiat Tan, Ph D., serves as Chief Operating Officer of CytoMed Therapeutics Limited since February 2019 and also serves as its Director since April 18, 2023. He serves as Co-Chief Executive Officer...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 6.7yrs | S$36.05k | 5.18% $ 1.4m | |
| Co-CEO, COO & Director | 5.8yrs | S$116.30k | 0.043% $ 11.5k | |
| Chief Scientific & Medical Officer and Director | 5.3yrs | S$118.43k | 5.11% $ 1.4m | |
| Chief Financial Officer | 4.7yrs | データなし | データなし | |
| Chief Clinical Officer | 1.6yrs | データなし | 0.80% $ 213.4k | |
| Chief Corporate Officer | 6.4yrs | データなし | データなし |
5.5yrs
平均在職期間
37.5yo
平均年齢
経験豊富な経営陣: GDTC's management team is seasoned and experienced (5.5 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 6.7yrs | S$36.05k | 5.18% $ 1.4m | |
| Co-CEO, COO & Director | 1.6yrs | S$116.30k | 0.043% $ 11.5k | |
| Chief Scientific & Medical Officer and Director | 1.6yrs | S$118.43k | 5.11% $ 1.4m | |
| Independent Director | 1.6yrs | データなし | データなし | |
| Independent Director | 1.6yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 1.6yrs | データなし | データなし | |
| Independent Director | 1.6yrs | データなし | データなし | |
| Independent Director | 1.6yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 1.6yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 1.6yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 1.6yrs | データなし | 7.66% $ 2.0m |
1.6yrs
平均在職期間
57yo
平均年齢
経験豊富なボード: GDTC's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.